November 14, 2023. T-CURX attends PEGS-Europe conference

T-CURX leadership team members will attend and present at PEGS-Europe conference in Lisbon, Portugal from November 14-16, 2023

T-CURX leadership team members, Michael Hudecek (T-CURX co-founder and CMO), Ulf Grawunder (T-CURX co-founder and CEO) and Jan Van den Brulle (T-CURX Head Preclinical Research) are attending and presenting at the 2023 PEGS Europe Protein and Antibody Engineering Summit organized by Cambridge Healthtech Institute at Lisbon Congress Center in Lisbon, Portugal, from November 14-16, 2023. PEGS Europe is one of the leading biologics technology meetings in Europe with an expected attendance of over 1'000 attendees. This year's summit will feature a dedicated stream focused on innovations in CAR-T therapies. Michael Hudecek (CMO) will hold a keynote speach about "New Targets and Technologies for CAR-T cells" taking place on Nov 15, 5 p.m. He will also participate in a panel discussion "What is the next gamer changer in the car T cell field" co-chaired by Ulf Grawunder and Astero Klampatsa, taking place on Nov 15, 6:30 p.m. In addition, Ulf will also be the chairman of two CAR-T sessions about "In vivo developments and delivery using LNPs and mRNA", as well as "Optimising CARs" in the afternoon of Nov 15, starting at 2:30 p.m.